Articles
RSSMedtronic Initiates Phase II Hepatitis C Clinical Study ''COPE-HCV'' To Determine Tolerability And Safety Of Continuous Interferon Infusion For Patients With HCV
September 2, 2009
You can view this news at http://www.businesswire.com/news/home/20090902005124/en.
